Canada’s Cancer Report Card
Leadership Perspectives, Episode 18
Canada’s track record on mortality rates due to cancer isn’t as good as you might think. Isabelle Gagnon-Arpin joins us to talk about provincial disparities, COVID-19’s impact on cancer detection, and how we measure up internationally.
The full story: Measure of Life: Is Canada Doing Enough to Reduce Deaths from Cancer?
Isabelle Gagnon-Arpin
Former Principal Research Associate, Signal49 Research
Require an accessible version of this podcast?
Upon request, Signal49 Research offers accessible versions of our podcasts. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Related Insights
-
Fighting for Canadian Access to Breakthrough Treatments, Now
This op-ed was originally published by Toronto Star on March 20, 2022. There’s arguably nothing more devastating than hearing that…
-
Canada’s Attention to Dementia Care has Waned
This op-ed was originally published by iPoltics on April 8, 2022. Canada should capture the moment before it fades, and…
-
Out of the Lab, into the Patient: Canada’s Commercial Opportunity in Cell and Gene Therapy Manufacturing
Originally produced for the Innovation Economy Council (IEC). The IEC is now the Signal49 Research’s Canadian Centre for the Innovation…
Comments